This federal bill mandates that health insurance policies must cover pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) HIV medications, along with related laboratory tests and patient visits. The purpose is to ensure broader access to preventive and treatment measures for HIV/AIDS. This legislation aims to reduce barriers to obtaining crucial medications and services for individuals at risk of or exposed to HIV, potentially leading to improved public health outcomes by expanding access to essential care.
2023-05-19: Referred to HEALTH
Contribute Your Insights: Add a Unique Perspective to Political Bills. Your Contribution will be Featured Below the Primary Bill, Ordered by Date Added.
No Reviews found ..